Status
Conditions
About
Background:
Many advances have been made in cancer treatments, but more research is needed. Comparing samples of cancerous tissue to samples of normal, noncancerous tissues may help find differences between them. These differences may help researchers find new ways to treat cancer.
Objective:
To collect tissues and blood samples from people with known or suspected cancer. The samples will be used to help identify new targets for cancer treatments.
Eligibility:
People aged 18 years and older with a known or suspected cancer that requires surgery or biopsy.
Design:
Participants will be screened. They will answer questions about their health. They can do this on the phone or in person.
Researchers will collect information from participants medical records. Data may include information about any prior or current cancers. Data about other medical conditions may also be collected.
Participants will have blood drawn. Some of the blood will be tested for HIV and hepatitis B and C. Some of the blood will be used for genetic research.
Participants will have tissue samples collected during surgeries or biopsies. These are procedures the participants would have had as part of their standard care. No new procedures will be done just for this study. Researchers may also seek out samples from prior procedures the participant had done.
Participants will remain in the study for 6 months. They may have blood drawn again. Researchers may also collect tissue samples from any procedures performed during that time.
Full description
Background:
Objective:
To collect biologic samples from participants undergoing diagnostic or therapeutic interventions for known or suspected cancer for the purpose of identifying novel molecular and biologic therapeutic targets and studying the intratumoral immune landscape.
Eligibility:
Participants >=18 years of age with suspected or confirmed malignancies planning diagnostic or therapeutic intervention from which biologic samples may be obtained.
Design:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Note: Participants will not be enrolled exclusively for the procurement of tissue samples.
-Able and willing to sign an informed consent document.
1,200 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal